[Potentiation of the antitumor action of alkylating compounds by amphotericin B].
D000477:Alkylating Agents / Q000494:pharmacology*; D000666:Amphotericin B / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003520:Cyclophosphamide / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D013852:Thiotepa / Q000494:pharmacology
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D000666:Amphotericin B; D003520:Cyclophosphamide; D013852:Thiotepa
O potentsirovanii protivoopukholevogo deĭstviia alkiliruiushchikh soedineniĭ amfoteritsinom B